Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Grace Therapeutics, Inc
GRCE
Healthcare
Biotechnology
Grace Therapeutics, Inc., formerly Acasti Pharma Inc., is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of over 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is a clinical-stage, novel...
, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aneurysmal subarachnoid hemorrhage (aSAH) patients to address significant unmet medical needs. GTX-104 provides a convenient IV delivery of nimodipine in the intensive care unit, eliminating the need for nasogastric tube administration in unconscious or dysphagic patients. Its other pipeline drug candidates include GTX-102, which is an oral-mucosal betamethasone spray for the treatment of Ataxia Telangiectasia and GTX-101, which is a topical bio adhesive film-forming bupivacaine spray for Postherpetic Neuralgia.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:GRCE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
(561)
•••
Justhalffull
X
Post by
Justhalffull
on Sep 05, 2021 4:27pm
For the record
If you had invested $10,000 on Feb 7 2012, you would now have 245.87. If you need any more evidence about this outfit, you should not be investing in stocks.
(4)
•••
19LDS84
X
Post by
19LDS84
on Sep 05, 2021 4:21pm
Nice to see the reverse split went well
Not we can lose more money on this lower board of directors. Why not just admit you suck and go get a real job and stop taking peoples money to dump. Clearly they don't have a clue what they'
...more
(2)
•••
Weeble
X
Comment by
Weeble
on Sep 03, 2021 7:53pm
RE:RE:RE:Successful Completion of its Merger with Grace Therapeutics
No volume and no interest while insiders reward themselves for a job poorly done. Who bought into the Jan D'Alvise BS? How long will she have a job? Too long!
(55)
•••
Canadian_101
X
Comment by
Canadian_101
on Sep 01, 2021 4:22pm
RE:RE:Successful Completion of its Merger with Grace Therapeutics
Games, games and more games, so glad I dumped this one and moved on.....
(52)
•••
Francine01
X
Comment by
Francine01
on Sep 01, 2021 9:08am
RE:RE:RE:RE:RE:RE:Successful Completion of its Merger with Grace Therapeutics
Hi Weeble, its called a technical trade because 17% haircut for a pure reverse split annoncent a month ago was too much. Even if Jan is the worst CEO in north america, I presume that she will
...more
(2)
•••
Weeble
X
Comment by
Weeble
on Aug 31, 2021 8:35pm
RE:RE:RE:RE:RE:Successful Completion of its Merger with Grace Therapeutics
Francine, are you a masochist? Good luck to you but I would never invest in a company where I didn't trust or like the CEO.
(52)
•••
Francine01
X
Comment by
Francine01
on Aug 31, 2021 11:24am
RE:RE:RE:RE:Successful Completion of its Merger with Grace Therapeutics
I sold my position during the 1.20US/1.50Cdn rally. Now buying at the equivalent of 34 cents is very compelling. I bought a small position this morning and will average down. For Janelle, we
...more
(12)
•••
Careless2again2
X
Comment by
Careless2again2
on Aug 31, 2021 9:41am
RE:RE:RE:Successful Completion of its Merger with Grace Therapeutics
...exactly and part of deal is the inability to remove her...
(2)
•••
Weeble
X
Comment by
Weeble
on Aug 29, 2021 8:58pm
RE:RE:Successful Completion of its Merger with Grace Therapeutics
The 8 to 1 just allows them to dilute the stock again. How do you get rid of Jan D'Alvise? That is the big question. If she ever bought on the open market, I
...more
(2127)
•••
lscfa
X
Comment by
lscfa
on Aug 27, 2021 9:37am
RE:Successful Completion of its Merger with Grace Therapeutics
Acasti confirms that a reverse split of its common stock at an 8-1 ratio will be implemented to help regain compliance with NASDAQ minimum bid price rule,
(2830)
•••
Betteryear2
X
Post by
Betteryear2
on Aug 27, 2021 8:50am
Successful Completion of its Merger with Grace Therapeutics
LAVAL, Qubec, Aug. 27, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti”) (NASDAQ: ACST–TSX-V: ACST), announced today the completion of its previously disclosed acquisition of Grace
...more
(4)
•••
19LDS84
X
Post by
19LDS84
on Aug 05, 2021 11:02pm
Crickets
Hello? Anybody home?
(15)
•••
alanmar1
X
Post by
alanmar1
on May 11, 2021 6:10pm
Grace merger
This provides Acasti with a reason to exist after they announce the marketing of the Care Pre product. Existing shareholder will own 55% of the new shares and Grace will have 45% There is
...more
(358)
•••
sam2100
X
Comment by
sam2100
on May 07, 2021 3:35pm
RE:RE:Merger
GREAT MOVE !!!!!!!!!!!!!!!!!!!!!!!!
(100)
•••
GajjarDr
X
Comment by
GajjarDr
on May 07, 2021 2:59pm
RE:TSXV:ACST ~ Agrees to acquire Grace Therapeutics !!
New Video Out Now
Grace will provide Acasti with a pipeline of
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
The world's largest undeveloped diamond deposit is trading at a discount
A Canadian Company Focused on Exploring and Developing Saskatchewan’s Diamond Resources
Have you held units of a TD mutual fund, other than through a discount broker? Learn more.